| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.6M | -4.8% | -19.2% |
| Cost of Revenue | $3.2M | -3.7% | -10.3% |
| Gross Profit | $4.4M | -5.5% | -24.6% |
| R&D Expense | $4.3M | -4.9% | -33.5% |
| SG&A Expense | $5.4M | +5.5% | +10.2% |
| Operating Income | -$8.4M | +0.7% | +26.4% |
| Pre-tax Income | -$8.1M | +0.8% | +24.2% |
| Income Tax | $5K | +25.0% | +150.0% |
| Net Income | -$8.2M | +0.8% | +24.2% |
| EPS (Basic) | -$0.38 | +0.0% | +24.0% |
| EPS (Diluted) | -$0.38 | +0.0% | +24.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $9.1M | -10.0% | -64.4% |
| Short-term Investments | $3.5M | -42.1% | -57.4% |
| Accounts Receivable | $6.3M | -0.6% | -9.2% |
| Current Assets | $21.8M | -13.4% | -51.4% |
| Total Assets | $55.4M | -8.7% | -34.8% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$12.8M | — | — |
| Capital Expenditures | $474K | — | — |
| Investing Cash Flow | $12.0M | — | — |
| Financing Cash Flow | -$2.5M | — | — |
| Free Cash Flow | -$13.2M | — | — |
| $9.4M |
| +0.1% |
| +0.6% |
| Total Liabilities | $14.0M | -1.5% | -5.5% |
| Stockholders' Equity | $41.4M | -11.0% | -41.0% |